An NPR Blue Ridge Radio reports that a Durham-based life sciences company received promising test results on a new medical device that could become an in-home treatment for the coronavirus. Michael Knowles, MD, the Michael E. Hatcher Distinguished Professor of Medicine in the division of pulmonary diseases and critical care medicines, commented in a statement distributed by EmitBio.
“Vaccines are a front-line necessity, and even though they have an incredibly high level of protection at over 90%, people aren’t going to just return to normal daily living without regard for this virus,” said Knowles.
“To have an at-home treatment available to use at the first signs of symptoms can help us all return to pre-COVID life.”
Read the news story here.
Find the press release announcement here on PR Newswire: EmitBio Announces Positive Clinical Results Supporting A Novel Therapeutic For COVID-19.